Clinical Trials Logo

Clinical Trial Summary

The aim of this randomized controlled study is to compare the efficacy of biodegradable internal pancreatic stenting versus no stenting in patients undergoing pancreatoduodenectomy (PD), focusing on a possible superiority association of the device in preventing clinically relevant postoperative pancreatic fistula (CR-POPF). Patients undergoing PD will be randomized into two arms: - arm 1: a biodegradable internal pancreatic stent will be placed at the level of the pancreatic anastomosis - arm 2: no pancreatic stent will be placed at the level of the pancreatic anastomosis The rate of occurrence of CR-POPF will be compared between the two arms.


Clinical Trial Description

Clinically relevant postoperative pancreatic fistula (CR-POPF) represents the most common complication that can occur after pancreatoduodenectomy (PD). CR-POPF is the main cause of morbidity after PD, being associated with a risk of mortality up to 60%. The placement of external or internal pancreatic stents after PD have been investigated as possible strategies for preventing the development of CR-POPF. However, device displacement has been reported as a common cause of pancreatic stents malfunction. Recently, a novel biodegradable pancreatic stent (ARCHIMEDES™) has been introduced. The device has been specifically designed to reduce the risk of displacement, thus offering a new valuable tool to decrease the rate of CR-POPF after PD. In this randomised, controlled, single-center trial, researchers investigate the possible efficacy of biodegradable internal pancreatic stenting of pancreatic anastomosis in patient undergoing PD versus no stenting, focusing on a possible superiority association for preventing CR-POPF. Participants will be randomised into two arms (Biodegradable stent vs non-stent) based on their intra-operative risk of developing POPF according to the Fistula Risk Score (FRS). The rate of CR-POPF will be compared between the two arms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05668260
Study type Interventional
Source Ospedale San Raffaele
Contact Massimo Falconi, Professor
Phone 0039 022643 6046
Email falconi.massimo@hsr.it
Status Recruiting
Phase N/A
Start date January 25, 2023
Completion date January 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06289803 - The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery N/A
Completed NCT05109143 - Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy N/A
Completed NCT02588066 - Pancreatoduodenectomy With or Without Ligamentum Teres Wrap Around Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage N/A
Completed NCT01984216 - Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy N/A
Not yet recruiting NCT06319755 - Characteristics of Intestinal Microbiome Following Pancreatic Surgery
Recruiting NCT05703581 - Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy
Not yet recruiting NCT05895214 - Mesopancreas Study in Pancreatic Cancer
Completed NCT03850236 - Neck Division Level and Postoperative Pancreatic Fistula After Pancreaticoduodenectomy
Not yet recruiting NCT03754595 - Application of 2D and 3D Laparoscopy in Laparoscopic Pancreaticoduodenectomy: a Prospective Randomized Clinical Trial N/A
Completed NCT05573399 - Early Oral Feeding for Patients After Pancreaticoduodenectomy
Completed NCT04381702 - Outcome After Laparoscopic Versus Open Pancreaticoduodenectomy